Previous Page  191 / 1363 Next Page
Information
Show Menu
Previous Page 191 / 1363 Next Page
Page Background

Contrast Agents

Gadolinium agents better

tolerated than iodinated (CT)

agents

Gd-DTPA (Magnevist) safety

record:

5 million uses, 1,234 AEs

(1992)

Anaphylactic shock and death

in 1 case

nephrogenic systemic fibrosis (NSF)

in kidney dysfunction

Macrocyclic agents (Dotarem, Prohance, Gadovist)

more commonly used IV

EMA recently suspended linear agents (Magnevist,

Optimark, Omniscan)